CGY Stock Analysis: Calian Technologies | TO

Aerospace & Defense | TO, Canada | Market Cap: 1.029m CAD | 12M Return: 65.3% | CA12989J1084 | Charts, Fundamentals & Technical Analysis

Satellite Communications, Cybersecurity, Digital Health, Corporate Training
Total Rating 60
Safety 77
Buy Signal 0.54
Diversified Support Services
Sub-Industry Rotation: +5.8
Market Cap: 721M
Avg Turnover: 2.34M
Risk 3d forecast
Volatility34.1%
VaR 5th Pctl5.39%
VaR vs Median-3.92%
Reward TTM
Sharpe Ratio1.29
Rel. Str. IBD83.4
Rel. Str. Peer Group64.6 pctl
Character TTM
Beta0.390
Beta Downside0.638
Hurst Exponent0.544
Choppyness71.4%
Drawdowns 3y
Max DD36.15%
CAGR/Max DD0.56
CAGR/Mean DD1.59
EPS (Earnings per Share) EPS (Earnings per Share) of CGY over the last years for every Quarter: "2021-09": 0.82, "2021-12": 0.85, "2022-03": 1.16, "2022-06": 0.95, "2022-09": 0.9, "2022-12": 0.75, "2023-03": 0.9, "2023-06": 0.71, "2023-09": 1.07, "2023-12": 0.86, "2024-03": 1.46, "2024-06": 0.45, "2024-09": 0.96, "2024-12": 0.88, "2025-03": 0.93, "2025-06": 1, "2025-09": 1, "2025-12": 1.03, "2026-03": 1.3, "2026-06": 1.1,
EPS CAGR: 6.09%
EPS Trend: 58.4%
Last SUE: 0.88
Qual. Beats: 2
Revenue Revenue of CGY over the last years for every Quarter: 2021-09: 127.639, 2021-12: 129.502, 2022-03: 142.102, 2022-06: 150.018, 2022-09: 160.55, 2022-12: 147.543, 2023-03: 168.543, 2023-06: 166.55, 2023-09: 175.948, 2023-12: 179.179, 2024-03: 201.268, 2024-06: 184.998, 2024-09: 181.166, 2024-12: 185.047, 2025-03: 193.667, 2025-06: 192.216, 2025-09: 203.181, 2025-12: 208, 2026-03: 228.701, 2026-06: 230.397,
Rev. CAGR: 8.24%
Rev. Trend: 94.7%
Last SUE: 1.63
Qual. Beats: 2

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.8 years of data, until 10/2026

Jan +0.0% 0
Feb +5.2% 4
Mar -4.5% 14
Apr +1.1% 14
May -1.2% 4
Jun +0.6% 4
Jul +1.2% 14
Aug -0.6% 14
Sep -1.6% 4
Oct -0.7% 4
Nov +2.5% 9
Dec -0.9% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: CGY Calian Technologies

Calian Group Ltd. is a Canada-based provider of business services and technology solutions, serving customers in Canada and internationally. Its four segments-Advanced Technologies, Health, Learning, and IT and Cyber Solutions-cover areas including satellite communications, cybersecurity, healthcare, workforce training, engineering, and emergency preparedness.

The company serves public- and private-sector industries such as defense, government, transportation, energy, and manufacturing. Its diversified model combines specialized products with managed services, consulting, training, and engineering support.

Headlines to Watch Out For
  • Canadian defense spending and satellite demand expand Advanced Technologies backlog
  • Health contract renewals and service mix drive segment revenue and margins
  • Acquisition integration and debt reduction shape cash flow and capital returns
Piotroski VR-10 (Strict) 4.0
Net Income: 38.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.24 > 1.0
NWC/Revenue: 14.64% < 20% (prev 11.20%; Δ 3.44% < -1%)
CFO/TA 0.05 > 3% & CFO 38.0m > Net Income 38.4m
Net Debt (181.5m) to EBITDA (105.6m): 1.72 < 3
Current Ratio: 1.61 > 1.5 & < 3
Outstanding Shares: last quarter (11.7m) vs 12m ago 2.01% < -2%
Gross Margin: 31.74% > 18% (prev 33.80%; Δ -2.06% > 0.5%)
Asset Turnover: 117.6% > 50% (prev 103.9%; Δ 13.70% > 0%)
Interest Coverage Ratio: 6.16 > 6 (EBIT TTM 60.1m / Interest Expense TTM 9.75m)
Altman Z'' 2.91
A: 0.17 (Total Current Assets 335.2m - Total Current Liabilities 207.7m) / Total Assets 756.0m
B: 0.12 (Retained Earnings 92.5m / Total Assets 756.0m)
C: 0.08 (EBIT TTM 60.1m / Avg Total Assets 739.8m)
D: 0.82 (Book Value of Equity 340.0m / Total Liabilities 416.0m)
Altman-Z'' = 2.91 = A
Beneish M -2.80
DSRI: 1.13 (Receivables 209.6m/160.1m, Revenue 870.3m/752.1m)
GMI: 1.06 (GM 33.80% / 31.74%)
AQI: 0.92 (AQ_t 0.45 / AQ_t-1 0.49)
SGI: 1.16 (Revenue 870.3m / 752.1m)
TATA: 0.00 (NI 38.4m - CFO 38.0m) / TA 756.0m)
Beneish M = -2.80 (Cap -4..+1) = A
What is the price of CGY shares?

As of November 17, 2026, the stock is trading at CAD 85.55 with a total of 26,467 shares traded. Over the past week, the price has changed by +0.68%, over one month by +5.54%, over three months by -6.25% and over the past year by +65.26%.

Current recommended Stop Loss: 79.60 (which is 7% or 2.3 ATR below the current price).

Is CGY a buy, sell or hold?

Calian Technologies has no consensus analysts rating.

Calian Technologies (CGY) - Fundamental Data Overview as of 11 November 2026
Market Cap USD = 721.2m (1.03b CAD * 0.7007 CAD.USD)
P/E Trailing = 27.0667
P/E Forward = 19.1205
P/S = 1.1826
P/B = 3.0285
Revenue TTM = 870.3m CAD
EBIT TTM = 60.1m CAD
EBITDA TTM = 105.6m CAD
Long Term Debt = 141.2m CAD (from longTermDebt, last quarter)
Short Term Debt = 6.20m CAD (from shortTermDebt, last quarter)
Debt = 227.8m CAD (from shortLongTermDebtTotal, last quarter) + Leases 43.3m
Net Debt = 181.5m CAD (calculated: Debt 227.8m - CCE 46.3m)
Enterprise Value = 1.21b CAD (1.03b + Debt 227.8m - CCE 46.3m)
Interest Coverage Ratio = 6.16 (Ebit TTM 60.1m / Interest Expense TTM 9.75m)
EV/FCF = 45.97x (Enterprise Value 1.21b / FCF TTM 26.3m)
FCF Yield = 2.18% (FCF TTM 26.3m / Enterprise Value 1.21b)
FCF Margin = 3.03% (FCF TTM 26.3m / Revenue TTM 870.3m)
Net Margin = 4.41% (Net Income TTM 38.4m / Revenue TTM 870.3m)
Gross Margin = 31.74% ((Revenue TTM 870.3m - Cost of Revenue TTM 594.0m) / Revenue TTM)
Gross Margin QoQ = 29.15% (prev 30.26%)
Tobins Q-Ratio = 1.60 (Enterprise Value 1.21b / Total Assets 756.0m)
Interest Expense / Debt = 4.28% (Interest Expense 9.75m / Debt 227.8m)
Taxrate = 21.00% (10.2m / 48.6m)
NOPAT = 47.5m (EBIT 60.1m * (1 - 21.00%))
Current Ratio = 1.61 (Total Current Assets 335.2m / Total Current Liabilities 207.7m)
Debt / Equity = 0.67 (Debt 227.8m / totalStockholderEquity, last quarter 340.0m)
Debt / EBITDA = 1.72 (Net Debt 181.5m / EBITDA 105.6m)
Debt / FCF = 6.89 (Net Debt 181.5m / FCF TTM 26.3m)
Total Stockholder Equity = 328.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 38.4m / Total Assets 756.0m)
RoE = 11.67% (Net Income TTM 38.4m / Total Stockholder Equity 328.9m)
RoCE = 12.79% (EBIT 60.1m / Capital Employed (Equity 328.9m + L.T.Debt 141.2m))
RoIC = 9.29% (NOPAT 47.5m / Invested Capital 511.0m)
WACC = 6.31% (E(1.03b)/V(1.26b) * Re(6.96%) + D(227.8m)/V(1.26b) * Rd(4.28%) * (1-Tc(0.21)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.33 | Cagr: -1.22%
[DCF] Terminal Value 73.10% ; FCFF base≈35.3m ; Y1≈30.9m ; Y5≈25.0m
[DCF] Fair Price = 19.06 (EV 401.1m - Net Debt 181.5m = Equity 219.6m / Shares 11.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 58.36 | EPS CAGR: 6.09% | SUE: 0.88 | # QB: 2
Revenue Correlation: 94.67 | Revenue CAGR: 8.24% | SUE: 1.63 | # QB: 2
EPS current Quarter (2026-12-31): EPS=1.02 | Chg30d=+1.59% | Revisions=+0% | Analysts=4
EPS current Year (2026-09-30): EPS=4.26 | Chg30d=+0.36% | Revisions=+0% | GrowthEPS=+29.7% | GrowthRev=+14.4%
EPS next Year (2027-09-30): EPS=4.77 | Chg30d=-1.00% | Revisions=+29% | GrowthEPS=+12.0% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: +29% (up=3, down=1)